Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
Cascinu S, Catalano V, Piga A, Mattioli R, Marcellini M, Pancotti A, Bascioni R, Torresi U, Silva RR, Pieroni V, Giorgi F, Catalano G, Cellerino R. Cascinu S, et al. Among authors: mattioli r. Cancer Invest. 2003;21(5):701-7. doi: 10.1081/cnv-120023769. Cancer Invest. 2003. PMID: 14628428 Clinical Trial.
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer.
Cascinu S, Silva RR, Labianca R, Barni S, Mattioli R, Martignoni G, Frontini L, Gasparini G, Catalano V, Baldelli AM, Giuliodori L, Agostinelli R, Catalano G. Cascinu S, et al. Among authors: mattioli r. Ann Oncol. 1999 Aug;10(8):985-7. doi: 10.1023/a:1008373817826. Ann Oncol. 1999. PMID: 10509163 Free article. Clinical Trial.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Rosati G, Lonardi S, Galli F, Di Bartolomeo M, Ronzoni M, Zampino MG, Banzi M, Zaniboni A, Pasini F, Bozzarelli S, Garattini SK, Ferrari D, Montesarchio V, Mambrini A, Ciuffreda L, Galli F, Pusceddu V, Carlomagno C, Bidoli P, Amoroso D, Bochicchio AM, Frassineti L, Corsi D, Bilancia D, Pastorino A, De Stefano A, Labianca R; TOSCA (Three or Six Colon Adjuvant) investigators. Rosati G, et al. Eur J Cancer. 2021 May;148:190-201. doi: 10.1016/j.ejca.2021.01.051. Epub 2021 Mar 18. Eur J Cancer. 2021. PMID: 33744715
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
Catalano V, Bergamo F, Cremolini C, Vincenzi B, Negri F, Giordani P, Alessandroni P, Intini R, Stragliotto S, Rossini D, Borelli B, Santini D, Sarti D, Rocchi MBL, Lonardi S, Falcone A, Zagonel V, Mattioli R, Graziano F. Catalano V, et al. Among authors: mattioli r. J Cancer Res Clin Oncol. 2020 Feb;146(2):493-501. doi: 10.1007/s00432-019-03077-w. Epub 2019 Nov 6. J Cancer Res Clin Oncol. 2020. PMID: 31691872
Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
Mazzanti P, Massacesi C, Rocchi MB, Mattioli R, Lippe P, Trivisonne R, Buzzi F, De Signoribus G, Tuveri G, Rossi G, Di Lullo L, Sturba F, Morale D, Catanzani S, Pilone A, Bonsignori M, Battelli T. Mazzanti P, et al. Among authors: mattioli r. Lung Cancer. 2003 Jul;41(1):81-9. doi: 10.1016/s0169-5002(03)00140-5. Lung Cancer. 2003. PMID: 12826316 Clinical Trial.
257 results